Molecules/CRENEZUMAB

CRENEZUMAB

Molecular Identity

AntibodyPhase 3

Mechanism of action: Amyloid-beta A4 protein inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

CRENEZUMABMABT-5102AMABT5102ARG-7412RG7412

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to CRENEZUMAB

Loading drug network...